Calla Lily Clinical Care Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Seed
- (In Progress)
- Latest Deal Amount
-
$3.24M
- Investors
-
8
Calla Lily Clinical Care General Information
Description
Developer of an intravaginal drug delivery platform designed to improve therapeutic administration for women's health and other medical applications. The company offers a proprietary drug-device combination platform supporting applications in miscarriage prevention, in vitro fertilization support, menopause, oncology, infectious diseases, and live biotherapeutics, enabling pharmaceutical companies and healthcare providers to enhance drug delivery, expand treatment options, and extend the lifecycle of existing therapies.
Contact Information
Website
www.callali.lyCorporate Office
- 5th Floor Charles House
- 108-110 Finchley Road
- London NW3 5JJ
- England, United Kingdom
Corporate Office
- 5th Floor Charles House
- 108-110 Finchley Road
- London NW3 5JJ
- England, United Kingdom
Calla Lily Clinical Care Timeline
Calla Lily Clinical Care Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Seed Round | 21-Apr-2025 | $3.24M | In Progress | Clinical Trials - Phase 2 | ||
| 10. Later Stage VC | 20-Nov-2025 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 19-Jan-2026 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 03-Apr-2025 | Completed | Clinical Trials - Phase 2 | |||
| 7. Accelerator/Incubator | 25-Mar-2025 | Completed | Clinical Trials - Phase 1 | |||
| 6. Seed Round | 30-Jan-2025 | Completed | Clinical Trials - Phase 1 | |||
| 5. Accelerator/Incubator | 17-Jun-2024 | Completed | Clinical Trials - Phase 1 | |||
| 4. Angel (individual) | 20-Mar-2024 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 31-Mar-2023 | $849K | $576K | Completed | Pre-Clinical Trials | |
| 2. Angel (individual) | 31-Oct-2022 | $576K | $576K | Completed | Pre-Clinical Trials |
Calla Lily Clinical Care Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 3,441,885 | $0.000013 | $0.15 | $0.15 | 1x | $0.15 | 9.15% | |
| Ordinary | 6,558,115 | $0.000013 | $0.1 | $0.1 | 1x | $0.1 | 17.43% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Calla Lily Clinical Care Comparisons
Industry
Financing
Details
Calla Lily Clinical Care Competitors (2)
One of Calla Lily Clinical Care’s 2 competitors is Merck, a Corporation company based in Darmstadt, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merck | Corporation | Darmstadt, Germany | ||||
| L.D. Collins & Co. | Corporation | London, United Kingdom |
Calla Lily Clinical Care Patents
Calla Lily Clinical Care Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026109544-A1 | Sample collection devices | Pending | 19-Nov-2024 | ||
| GB-202417014-D0 | Sample collections devices | Pending | 19-Nov-2024 | ||
| GB-2702541-A | Sample collections devices | Pending | 19-Nov-2024 | ||
| EP-4090517-A1 | Devices for insertion into a vaginal or rectal cavity | Pending | 16-Dec-2019 | ||
| GB-2590902-B | Devices for insertion into a vaginal or rectal cavity | Active | 16-Dec-2019 | B29C65/7882 |
Calla Lily Clinical Care Signals
Calla Lily Clinical Care Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ignite Healthcare Network | Accelerator/Incubator | |||
| Springboard Enterprises | Accelerator/Incubator | |||
| Corner Capital Management | Venture Capital | Minority | ||
| Embryo Ventures | Venture Capital | Minority | ||
| Odin Investments | PE/Buyout | Minority |
Calla Lily Clinical Care FAQs
-
When was Calla Lily Clinical Care founded?
Calla Lily Clinical Care was founded in 2021.
-
Where is Calla Lily Clinical Care headquartered?
Calla Lily Clinical Care is headquartered in London, United Kingdom.
-
What is the size of Calla Lily Clinical Care?
Calla Lily Clinical Care has 17 total employees.
-
What industry is Calla Lily Clinical Care in?
Calla Lily Clinical Care’s primary industry is Drug Delivery.
-
Is Calla Lily Clinical Care a private or public company?
Calla Lily Clinical Care is a Private company.
-
What is Calla Lily Clinical Care’s current revenue?
The current revenue for Calla Lily Clinical Care is .
-
How much funding has Calla Lily Clinical Care raised over time?
Calla Lily Clinical Care has raised $6.87M.
-
Who are Calla Lily Clinical Care’s investors?
Ignite Healthcare Network, Springboard Enterprises, Corner Capital Management, Embryo Ventures, and Odin Investments are 5 of 8 investors who have invested in Calla Lily Clinical Care.
-
Who are Calla Lily Clinical Care’s competitors?
Merck and L.D. Collins & Co. are competitors of Calla Lily Clinical Care.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process